Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (231-240 of 405) with videos related to

Pageof 41
Sort By:
Nature Medicine|August 23, 2011
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primatesNancy J Sullivan, Lisa Hensley, Clement Asiedu, et al.
Plos Pathogens|May 27, 2010
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus SpeciesLisa E Hensley, Sabue Mulangu, Clement Asiedu, et al.
The Lancet. Haematology|April 3, 2023
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trialChristopher Melani, Kennichi Dowdell, Stefania Pittaluga, et al.
Nature Communications|April 22, 2020
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's diseaseCecilia S Lindestam Arlehamn, Rekha Dhanwani, John Pham, et al.
Ebiomedicine|December 18, 2021
Deconvoluting virome-wide antibody epitope reactivity profilesDaniel R Monaco, Sanjay V Kottapalli, Florian P Breitwieser, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Humoral correlate of vaccine-mediated protection from tuberculosis identified in humans and non-human primatesNatasha S Kelkar, Nicholas C Curtis, Timothy P Lahey, et al.
Nature|February 5, 2025
Antibody prophylaxis may mask subclinical SIV infections in macaquesChristopher A Gonelli, Hannah A D King, SungYoul Ko, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccineBarney S Graham, Richard A Koup, Mario Roederer, et al.
Journal of Virology|December 16, 2025
Demonstration of <i>in vivo</i> efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodiesChristina L Gardner, Sergei Pletnev, Jinny L Liu, et al.
Science Immunology|February 28, 2025
Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapyVadim A Klenchin, Natasha M Clark, Nida K Keles, et al.
Pageof 41

Showing results (231-240 of 405) with videos related to

Sort By:
Pageof 41
Nature Medicine|August 23, 2011
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primatesNancy J Sullivan, Lisa Hensley, Clement Asiedu, et al.
Plos Pathogens|May 27, 2010
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus SpeciesLisa E Hensley, Sabue Mulangu, Clement Asiedu, et al.
The Lancet. Haematology|April 3, 2023
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trialChristopher Melani, Kennichi Dowdell, Stefania Pittaluga, et al.
Nature Communications|April 22, 2020
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's diseaseCecilia S Lindestam Arlehamn, Rekha Dhanwani, John Pham, et al.
Ebiomedicine|December 18, 2021
Deconvoluting virome-wide antibody epitope reactivity profilesDaniel R Monaco, Sanjay V Kottapalli, Florian P Breitwieser, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Humoral correlate of vaccine-mediated protection from tuberculosis identified in humans and non-human primatesNatasha S Kelkar, Nicholas C Curtis, Timothy P Lahey, et al.
Nature|February 5, 2025
Antibody prophylaxis may mask subclinical SIV infections in macaquesChristopher A Gonelli, Hannah A D King, SungYoul Ko, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccineBarney S Graham, Richard A Koup, Mario Roederer, et al.
Journal of Virology|December 16, 2025
Demonstration of <i>in vivo</i> efficacy, cryo-EM-epitope identification, and breadth of two anti-alphavirus bispecific single domain antibodiesChristina L Gardner, Sergei Pletnev, Jinny L Liu, et al.
Science Immunology|February 28, 2025
Adeno-associated viral delivery of Env-specific antibodies prevents SIV rebound after discontinuing antiretroviral therapyVadim A Klenchin, Natasha M Clark, Nida K Keles, et al.
Pageof 41